Original language | English (US) |
---|---|
Pages (from-to) | 1402-1403 |
Number of pages | 2 |
Journal | Journal of Diabetes Science and Technology |
Volume | 15 |
Issue number | 6 |
DOIs | |
State | Published - 2021 |
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Bioengineering
- Biomedical Engineering
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Diabetes Science and Technology, Vol. 15, No. 6, 2021, p. 1402-1403.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Clinical Experience of Continuous Glucose Monitoring in Pregnancy
AU - O’Malley, Grenye
AU - Rosenn, Barak
AU - Nosova, Emily V.
AU - Kudva, Yogish C.
AU - Scarpelli Shchur, Sophia
AU - Levister, Camilla
AU - Kaur, Ravinder
AU - Pinsker, Jordan E.
AU - Castorino, Kristin
AU - Church, Mei Mei
AU - Dassau, Eyal
AU - Levy, Carol J.
N1 - Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: GO receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution. BR has no disclosures to report. EVN has no disclosures to report. YCK receives consulting fees from Novo Nordisk and product support from Dexcom, Roche Diabetes, and Tandem Diabetes. SSS has no disclosures to report. CL receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution. RK has no disclosures to report. JEP is currently an employee of Tandem Diabetes Care, Inc. The work presented in the manuscript was performed as part of his academic appointment at Sansum Diabetes Research Institute and is independent of his employment with Tandem Diabetes Care. KC receives research support from Dexcom, Medtronic, Abbott, Insulet, and Novo Nordisk paid to her institution. MMC has no disclosures to report. ED reports receiving grants from JDRF, NIH, and Helmsley Charitable Trust, personal fees from Roche, Dexcom and Eli Lilly, patents on artificial pancreas technology, and product support from Dexcom, Insulet, Tandem, and Roche. ED is currently an employee and shareholder of Eli Lilly and Company. The work presented in this manuscript was performed as part of his academic appointment and is independent of his employment with Eli Lilly and Company. CJL receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution and has served as a consultant and CME speaker for Dexcom and as a consultant for Eli Lilly.
PY - 2021
Y1 - 2021
UR - http://www.scopus.com/inward/record.url?scp=85109097062&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109097062&partnerID=8YFLogxK
U2 - 10.1177/19322968211024668
DO - 10.1177/19322968211024668
M3 - Letter
C2 - 34218719
AN - SCOPUS:85109097062
SN - 1932-2968
VL - 15
SP - 1402
EP - 1403
JO - Journal of Diabetes Science and Technology
JF - Journal of Diabetes Science and Technology
IS - 6
ER -